# Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

> **NCT00249912** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 415 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Lapaquistat acetate and rosuvastatin
- **DRUG:** Lapaquistat acetate and rosuvastatin
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00249912
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2012-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249912, "Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00249912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*